在状细胞疾病患者群体中评估血栓预防:解决证据差距
Jennifer Davila1, Sarah H O'Brien2, William B Mitchell1
1Division of Pediatric Hematology-Oncology, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York, USA.
状细胞病 (SCD) 患者患血栓 (血栓栓塞),特别是静脉血栓塞 (VTE) 的风险更高. 需要基于证据的指导方针来预防这种脆弱人群的VTE.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 血管医学 血管医学
背景情况:
- 状细胞疾病 (SCD) 是一种由β-环球蛋白基因突变引起的遗传疾病.
- 突变血红蛋白S在氧气不足下聚合,导致状红细胞和各种并发症.
- SCD与高凝血状态有关,增加了血栓形成的风险.
研究的目的:
- 描述SCD患者的高凝血状态和高血栓形成风险.
- 倡导制定基于证据的VTE预防SCD的指导方针.
主要方法:
- 关于SCD病理生理学和血栓形成的文献综述.
- 对SCD中VTE发病率和死亡率的现有数据的分析.
- 讨论对血栓预防指导方针的需要.
主要成果:
- SCD患者表现出高凝血状态,导致并发症.
- 静脉血栓塞栓症 (VTE) 是SCD中死亡的一个重要原因.
- 目前缺乏SCD中VTE预防的指导方针.
结论:
- 在SCD中高凝血状态显著增加了VTE风险.
- 迫切需要基于证据的SCD血栓预防指南.
- 实施预防措施可以减少与SCD中VTE相关的死亡率.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
相关概念视频
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
